APA (7th ed.) Citation

Stauffer, V. L., Sniadecki, J. L., Piezer, K. W., Gatz, J., Kollack-Walker, S., Hoffmann, V. P., . . . Durell, T. (2010). Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder. BMC psychiatry, 10(1), 89. https://doi.org/10.1186/1471-244X-10-89

Chicago Style (17th ed.) Citation

Stauffer, Virginia L., Jennifer L. Sniadecki, Kevin W. Piezer, Jennifer Gatz, Sara Kollack-Walker, Vicki Poole Hoffmann, Robert Conley, and Todd Durell. "Impact of Race on Efficacy and Safety During Treatment with Olanzapine in Schizophrenia, Schizophreniform or Schizoaffective Disorder." BMC Psychiatry 10, no. 1 (2010): 89. https://doi.org/10.1186/1471-244X-10-89.

MLA (9th ed.) Citation

Stauffer, Virginia L., et al. "Impact of Race on Efficacy and Safety During Treatment with Olanzapine in Schizophrenia, Schizophreniform or Schizoaffective Disorder." BMC Psychiatry, vol. 10, no. 1, 2010, p. 89, https://doi.org/10.1186/1471-244X-10-89.